CONCORDBIO.BOCONCORDBIO.BOBSE
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+10.1%
5Y CAGR+21.7%
Studio
Year-over-Year Change

Expenses from normal business operations (SG&A, R&D, etc.)

3Y CAGR
+10.1%/yr
Annual compound
5Y CAGR
+21.7%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
2.7x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$1.66B+14.0%
2024$1.46B+2.0%
2023$1.43B+14.7%
2022$1.25B+78.4%
2021$699.61M+12.1%
2020$624.20M-